ERY-TAB DR 333 MG TABLET

Erythromycin
$8.5150per EA

Strength

333 mg/1

NDC

24338012413

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Last Updated

1/17/2018

Active Ingredients

ERYTHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA062298

On Market Since

4/18/2011

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+308.2%